Why New Treatments are Needed for the Management of Psoriasis
[themo_button text=”Participate Now” url=”https://www.cmeoutfitters.com/transfers/cm/?ID=46867″ type=”standard” target=”_blank”] |
This CME Outfitters Snack will evaluate the factors that are associated with patient perspectives on disease burden, address that burden, and the unmet treatment needs in the management of PsO, in order to show why new treatments are needed. |
Refining Treatment Targets for the Management of Psoriasis
[themo_button text=”Participate Now” url=”https://www.cmeoutfitters.com/transfers/cm/?ID=46868″ type=”standard” target=”_blank”] |
In this CME Outfitters Snack, expert faculty evaluate the role of TYK2 versus JAK1, JAK2, and JAK3 signaling pathways in PsO as the differences in mechanisms of action offer new and effective options for patients with PsO. |
Forecasting a Bright and Clear Tomorrow for Psoriasis Treatment
[themo_button text=”Participate Now” url=”https://www.cmeoutfitters.com/transfers/cm/?ID=46869″ type=”standard” target=”_blank”] |
This CME Outfitters Snack will focus on evaluating the efficacy and safety data for these emerging therapies, and on engaging patients in discussion about their treatment goals to improve treatment choices. |